Ginkgo Bioworks Holdings (DNA) Acquisitions (2021 - 2024)
Ginkgo Bioworks Holdings posted quarterly Acquisitions of $5.4 million for Q1 2024, up 157.8% on a QoQ basis from -$9.3 million in Q4 2021.
Ginkgo Bioworks Holdings (DNA) has 2 years of Acquisitions data on file, last reported at $5.4 million in Q1 2024.
- For the quarter ending Q1 2024, Acquisitions changed N/A year-over-year to $5.4 million; the trailing twelve-month figure through Dec 2024 stood at $5.4 million (changed N/A YoY), and the FY2024 full-year result was $5.4 million, changed N/A from the prior year.
- Acquisitions for Q1 2024 stood at $5.4 million, up from -$9.3 million in the prior quarter.
- Across five years, Acquisitions topped out at $20.2 million in Q3 2021 and bottomed at -$9.3 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 5.40 Mn |
| Dec 31, 2021 | -9.34 Mn |
| Sep 30, 2021 | 20.17 Mn |
| Mar 31, 2021 | 1.21 Mn |